No Data
No Data
Ekso Bionics Holdings Price Target Maintained With a $9.00/Share by HC Wainwright & Co.
Ekso Bionics Holdings Analyst Ratings
Lake Street Maintains Ekso Bionics(EKSO.US) With Buy Rating, Maintains Target Price $2
Ekso Bionics | 8-K: Ekso Bionics Reports Certain Preliminary Fourth Quarter 2024 Financial Results
Ekso Bionics Expects Q4 2024 Revenue Of $5M-$5.1M, Surpassing Q4 2023 Revenue Of $4.8M
Ekso Bionics Holdings Sees 4Q Rev $5M-$5.1M >EKSO
No Data